Currently, the primary efficacy measures for antidepressant clinical trials predominantly assess changes in mood symptoms in patients with major depressive disorder (MDD). When considering treatment ...

Phenotypic screening is a drug discovery approach that identifies bioactive compounds based on their ability to alter a cell or organism’s phenotype (observable characteristics) in a desired manner.

Suggested Citation: "1 Introduction." National Academies of Sciences, Engineering, and Medicine. 2019. Functional Assessment for Adults with Disabilities. Washington, DC: The National Academies Press.